|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||24.28 mL||121.4 mL||242.8 mL|
|0.5 mM||4.86 mL||24.28 mL||48.56 mL|
|1 mM||2.43 mL||12.14 mL||24.28 mL|
|5 mM||0.49 mL||2.43 mL||4.86 mL|
*The above data is based on the productmolecular weight 411.86. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
ZM323881 is a potent and selective inhibitor of human vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) with IC50 value of 2 nM.
Brivanib (BMS-540215) is a VEGFR -2 inhibitor with an IC50 of 25 nM and Ki of 26 nM.
BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as well as the VEGF receptor kina…
Imatinib (Gleevec) is a number of tyrosine kinase enzymes specific inhibitor.
Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 μM.
CP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor